253 related articles for article (PubMed ID: 2021542)
1. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Haybittle JL; Bennett MH; MacLennan KA; Jelliffe AM
Br J Cancer; 1991 Apr; 63(4):579-82. PubMed ID: 2021542
[TBL] [Abstract][Full Text] [Related]
2. Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
Hancock BW
Radiother Oncol; 1986 Nov; 7(3):215-21. PubMed ID: 3544084
[TBL] [Abstract][Full Text] [Related]
3. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
[TBL] [Abstract][Full Text] [Related]
4. LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.
Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Bennett MH; MacLennan KA; Haybittle JL; Anderson L; Linch DC
J Clin Oncol; 1992 Aug; 10(8):1252-8. PubMed ID: 1634914
[TBL] [Abstract][Full Text] [Related]
5. Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Druker BJ; Rosenthal DS; Canellos GP
Cancer; 1989 Mar; 63(6):1060-4. PubMed ID: 2917308
[TBL] [Abstract][Full Text] [Related]
6. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Rahim MA; Sarma SK; Ahmed Q
Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860
[TBL] [Abstract][Full Text] [Related]
7. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
8. Trials in advanced Hodgkin's disease: more than 30 years experience of the British National Lymphoma Investigation.
Zekri JM; Mouncey P; Hancock BW
Clin Lymphoma; 2004 Dec; 5(3):174-83. PubMed ID: 15636693
[TBL] [Abstract][Full Text] [Related]
9. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
Ekert H; Waters KD; Smith PJ; Toogood I; Mauger D
J Clin Oncol; 1988 Dec; 6(12):1845-50. PubMed ID: 3058876
[TBL] [Abstract][Full Text] [Related]
10. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
11. ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
Vose J; Armitage J; Weisenburger D; Moravec D; Hutchins M; Howe D; Sorensen S; Dowling M; Okerbloom J; Pevnick W
Am J Clin Oncol; 1988 Aug; 11(4):423-6. PubMed ID: 3407620
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Longo DL; Duffey PL; DeVita VT; Wiernik PH; Hubbard SM; Phares JC; Bastian AW; Jaffe ES; Young RC
J Clin Oncol; 1991 Aug; 9(8):1409-20. PubMed ID: 1712836
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Tannir N; Hagemeister F; Velasquez W; Cabanillas F
J Clin Oncol; 1983 Jul; 1(7):432-9. PubMed ID: 6199478
[TBL] [Abstract][Full Text] [Related]
15. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
16. ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
Cullen MH; Stuart NS; Woodroffe C; Murphy A; Fletcher J; Blackledge GR; Child JA; Grieve RJ; Jones EL
J Clin Oncol; 1994 Apr; 12(4):779-87. PubMed ID: 7512132
[TBL] [Abstract][Full Text] [Related]
17. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease in children in southern Africa: epidemiological characteristics, morbidity and long-term outcome.
Hesseling PB; Wessels G; Van Jaarsveld D; Van Riet FA
Ann Trop Paediatr; 1997 Dec; 17(4):367-73. PubMed ID: 9578798
[TBL] [Abstract][Full Text] [Related]
19. Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Brusamolino E; Orlandi E; Morra E; Castelli G; Pagnucco G; Livraghi A; Astori C; Santagostino A; Lazzarino M; Bernasconi C
Ann Oncol; 1994; 5 Suppl 2():53-7. PubMed ID: 7515648
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
Goldman JM
Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
